Literature DB >> 10764830

Remodeling of sugar chain structures of human interferon-gamma.

K Fukuta1, R Abe, T Yokomatsu, N Kono, M Asanagi, F Omae, M T Minowa, M Takeuchi, T Makino.   

Abstract

Natural human interferon (IFN)-gamma has mainly biantennary complex-type sugar chains and scarcely has multiantennary structures. We attempted to remodel the sugar chain structures using IFN-gamma as a model glycoprotein. To obtain the branching glycoforms of IFN-gamma, we introduced the genes for GnT-IV (UDP-N-acetylglucosamine:alpha-1,3-D-mannoside beta-1, 4-N-acetylglucosaminyltransferase) and/or GnT-V (UDP-N-acetylglucosamine:alpha-1,6-D-mannoside beta-1, 6-N-acetylglucosaminyltransferase) into Chinese hamster ovary (CHO) cells producing human IFN-gamma. The parental CHO cells produced IFN-gamma with biantennary sugar chains mainly. When the GnT-IV activity was increased, triantennary sugar chains with a branch produced by GnT-IV increased up to 66.9% of the total sugar chains. When the GnT-V activity was increased, triantennary sugar chains with a corresponding branch increased up to 55.7% of the total sugar chains. When the GnT-IV and -V activities were increased at a time, tetraantennary sugar chains increased up to 56.2% of the total sugar chains. The proportion of these multiantennary sugar chains corresponded to the intracellular activities of GnT-IV and -V. What is more, lectin blot and flow cytometric analysis indicated that the multi-branch structure of the sugar chains was increased not only on IFN-gamma, one of the secretory glycoproteins, but also on almost CHO cellular proteins by introducing either or both of the GnT genes. The results suggest that the branching structure of sugar chains of glycoproteins could be controlled by cellular GnT-IV and GnT-V activities. This technology can produce glycoforms out of natural occurrence, which should enlarge the potency of glycoprotein therapeutics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764830     DOI: 10.1093/glycob/10.4.421

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  11 in total

Review 1.  Emerging technologies for making glycan-defined glycoproteins.

Authors:  Lai-Xi Wang; Joseph V Lomino
Journal:  ACS Chem Biol       Date:  2011-12-14       Impact factor: 5.100

2.  Glycoengineering of Mammalian Expression Systems on a Cellular Level.

Authors:  Kelley M Heffner; Qiong Wang; Deniz Baycin Hizal; Özge Can; Michael J Betenbaugh
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases.

Authors:  K Fukuta; T Yokomatsu; R Abe; M Asanagi; T Makino
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

4.  Integrated transcriptome analysis of the cellular mechanisms associated with Ha-ras-dependent malignant transformation of the human breast epithelial MCF7 cell line.

Authors:  Franck Gadal; Christophe Bozic; Céline Pillot-Brochet; Sophie Malinge; Sarah Wagner; Aurélie Le Cam; Laurent Buffat; Michel Crepin; François Iris
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

5.  Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.

Authors:  Xiaotian Zhong; Jill F Wright
Journal:  Int J Cell Biol       Date:  2013-04-18

6.  Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation.

Authors:  Andrew G McDonald; Jerrard M Hayes; Tania Bezak; Sonia A Głuchowska; Eoin F J Cosgrave; Weston B Struwe; Corné J M Stroop; Han Kok; Teun van de Laar; Pauline M Rudd; Keith F Tipton; Gavin P Davey
Journal:  J Cell Sci       Date:  2014-09-30       Impact factor: 5.285

7.  Multiplexed engineering glycosyltransferase genes in CHO cells via targeted integration for producing antibodies with diverse complex-type N-glycans.

Authors:  Ngan T B Nguyen; Jianer Lin; Shi Jie Tay; Jessna Yeo; Terry Nguyen-Khuong; Yuansheng Yang
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

8.  Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells.

Authors:  Chung-Geun Lee; Myung Jin Oh; Seung-Yeol Park; Hyun Joo An; Jung Hoe Kim
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

Review 9.  Improving Immunotherapy Through Glycodesign.

Authors:  Matthew J Buettner; Sagar R Shah; Christopher T Saeui; Ryan Ariss; Kevin J Yarema
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

10.  Cloning, expression and immunoassay detection of ferret IFN-gamma.

Authors:  Atsuo Ochi; Ali Danesh; Charit Seneviratne; David Banner; Mark E Devries; Thomas Rowe; Luoling Xu; Longsi Ran; Markus Czub; Steven E Bosinger; Mark J Cameron; Cheryl M Cameron; David J Kelvin
Journal:  Dev Comp Immunol       Date:  2008-01-28       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.